By controlling the autophagy signaling system and cell cycle and functioning as an E3 ligase that ubiquitin-dependently degrades Fibrillin-1 (FBN1), FBXO2 has been shown to stimulate the growth of endometrial cancer (48). This evidence concerns the gene FBN1 and endometrial cancer.